Hormonal
Elevated levels of acetylcarnitine (C2) are associated with an increased risk of cardiovascular disease in patients with type 2 diabetes mellitus.
If you have Type 2 Diabetes, ask your doctor about checking acylcarnitine levels, specifically acetylcarnitine (C2). High levels may signal a higher risk for heart disease, even if your weight (BMI) looks normal. This finding suggests that managing metabolic health goes beyond just weight control and might require looking at specific metabolic markers to prevent cardiovascular issues.
Elevated C2 was associated with increased CVD risk in T2DM.
Why this rating
Cross-sectional observational study; association is strong but causality is not established.
Source
Acetylcarnitine Is Associated With Cardiovascular Disease Risk in Type 2 Diabetes Mellitus
Shuo Zhao et al. · Frontiers in Endocrinology · 2021
DOI 10.3389/fendo.2021.806819
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →